Sequential Local Injection of Low-Dose Interferon-Beta for Maintenance Therapy in Stage II and III Melanoma: A Single-Institution Matched Case-Control Study

A randomised phase II trial of 1month versus 1year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patients

(2011) Lili Mao et al.   EUROPEAN JOURNAL OF CANCER

Gene Regulatory and Clinical Effects of Interferon β in Patients with Metastatic Melanoma: A Phase II Trial

(2011) Ernest C. Borden et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects

(2011) C. Garbe et al.   ONCOLOGIST

Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis

(2010) S. Mocellin et al.   JNCI-Journal of the National Cancer Institute

poster presentation urological cancers

(2009)   ANNALS OF ONCOLOGY

Perilesional treatment of metastatic melanoma with interferon-β

(2009) T. Fujimura et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Interferon-β therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells

(2008) Hitomi Kubo et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update

(2008) Kazuyuki Ishihara et al.   International Journal of Clinical Oncology

A Pilot Study of Human Interferon   Gene Therapy for Patients with Advanced Melanoma by in vivo Transduction Using Cationic Liposomes

(2008) K. Matsumoto et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

(2008) Edward L. Korn et al.   JOURNAL OF CLINICAL ONCOLOGY